Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2007-10-09
2007-10-09
Saoud, Christine J. (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S192100, C435S069700, C514S002600, C514S012200, C530S350000, C530S387300, C536S023400
Reexamination Certificate
active
10880021
ABSTRACT:
Nucleic acid molecules and multimeric proteins capable of binding vascular endothelial growth factor (VEGF). VEGF traps are disclosed which are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells.
REFERENCES:
patent: 5851999 (1998-12-01), Ullrich
patent: 6011003 (2000-01-01), Charnock-Jones
patent: 6270993 (2001-08-01), Shibuya
patent: 7087411 (2006-08-01), Daly et al.
patent: WO 97/44453 (1997-11-01), None
patent: WO 98/13071 (1998-04-01), None
patent: WO 00/75319 (2002-12-01), None
Wulff, C. et al., (2002)Endocrinology, vol. 143, No. 7, pp. 2797-2807.
Heidaran, M.A. et al. (1990)The Journal of Biological Chemistry, vol. 265, No. 31, pp. 18741-18744.
Cunningham, S.A. et al. (1997)Biochemical and Biophysical Research Communications, vol. 231, pp. 596-599.
Fuh, G. et al., (1998)The Journal of Biological Chemistry, vol. 273, No. 18, pp. 11197-11204.
Wiesmann, C. et al., (1997)Cell, vol. 91, pp. 695-704.
Barleon, B. et al., (1997)The Journal of Biological Chemistry, vol. 272, No. 16, pp. 10382-10388.
Davis-Smyth, T. et al., (1998)The Journal of Biological Chemistry, vol. 273, No. 6, pp. 3216-3222.
Daly Thomas J.
Fandl James P.
Papadopoulos Nicholas J.
Gregg, Esq. Valeta
Lockard Jon M.
Regeneron Pharmaceuticals Inc.
Saoud Christine J.
LandOfFree
VEGF inhibitor polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with VEGF inhibitor polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and VEGF inhibitor polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3855725